Synopsys plans to stop offering manufacturing process control software. This move allows the company to divert resources to ...
Synopsys is reportedly ending its fab manufacturing control software to redirect engineers towards higher-margin AI chip design, sources tell Reuters.
The SEC has dropped its MetaMask enforcement case against ConsenSys with no fine, handing developers a key win in DeFi ...
Innoviz Technologies Ltd. (NASDAQ: INVZ) (the "Company" or "Innoviz"), a leading supplier of high-performance, ...
By Cynthia Kim and Hyunjoo Jin SEOUL, July 7 (Reuters) - U.S. chip design giant Synopsys plans to stop offering a suite of ...
GeoCue Announces TrueView LiDAR Payload Compatibility with Real-time Robotics Aerial Drone Platforms
New integration gives customers an NDAA-compliant aerial mapping solution backed by advanced UAS technology, TrueView LiDAR and LP360 software ...
Despite clarification from Anthropic, Alibaba will still enforce this strict policy starting from July 10, 2026.
The US cyber defence agency is reportedly using Anthropic’s AI model Mythos to identify vulnerabilities in government ...
Leadership is about recognising which important things matter more than all the others. Most leaders get it wrong.
CMS floats Medicare payment for AI diagnostic software, proposing a new category to standardize reimbursement for algorithm-driven clinical tools.
InvestorsHub on MSN
Synopsys to phase out chip manufacturing software as AI design becomes strategic focus (SNPS)
Synopsys shifts resources away from manufacturing software Synopsys (NASDAQ:SNPS) is preparing to discontinue a suite of ...
Synopsys (SNPS) plans to discontinue a suite of manufacturing process control software used by semiconductor manufacturers worldwide and reallocate resources to higher-margin business like AI design, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results